Perceived Barriers Among Clinicians and Older Adults Aged 65 and Older Regarding Use of Life Expectancy to Inform Cancer Screening: A Narrative Review and Comparison
Restricted accessReview articleFirst published online August, 2023
Perceived Barriers Among Clinicians and Older Adults Aged 65 and Older Regarding Use of Life Expectancy to Inform Cancer Screening: A Narrative Review and Comparison
While cancer screening guidelines increasingly recommend incorporating life expectancy estimates to inform screening decisions for older adults, little is known about how this happens in practice. This review summarizes current knowledge about primary care clinician and older adult (65+) perspectives about use of life expectancy to guide cancer screening decisions. Clinicians report operational barriers, uncertainty, and hesitation around use of life expectancy in screening decisions. They recognize it may help them more accurately weigh benefits and harms but are unsure how to estimate life expectancy for individual patients. Older adults face conceptual barriers and are generally unconvinced of the benefits of considering their life expectancy when making screening decisions. Life expectancy will always be a difficult topic for clinicians and patients, but there are advantages to incorporating it in cancer screening decisions. We highlight key takeaways from both clinician and older adult perspectives to guide future research.
AhmedS. U.BurkeM.McGuireM.MassareJ.BoydC. M.PollackC. E.. . .SchoenbornN. L. (2021). A novel curriculum on using life expectancy to inform cancer screening in older adults. Journal of the American Geriatrics Society, 69(2), 524–529.
2.
AustinJ. D.TehranifarP.RodriguezC. B.BrotzmanL.AgovinoM.ZiazadehD.. . .SheltonR. C. (2021). A mixed-methods study of multi-level factors influencing mammography overuse among an older ethnically diverse screening population: Implications for de-implementation. Implementation Science Communications, 2(1), Article 110. https://doi.org/10.1186/s43058-021-00217-7
3.
BreslauE. S.GorinS. S.EdwardsH. M.SchonbergM. A.SaiontzN.WalterL. C. (2016). An individualized approach to cancer screening decisions in older adults: A multilevel framework. Journal of General Internal Medicine, 31(5), 539–547.
4.
BrokaarE. J.van den BosF.VisserL. E.PortieljeJ. E. A. (2022). Deprescribing in older adults with cancer and limited life expectancy: An integrative review. American Journal of Hospice and Palliative Medicine, 39(1), 86–100. https://doi.org/10.1177/10499091211003078
5.
BrotzmanL. E.SheltonR. C.AustinJ. D.RodriguezC. B.AgovinoM.MoiseN.TehranifarP. (2022). “It’s something I’ll do until I die”: A qualitative examination into why older women in the U.S. continue screening mammography. Cancer Medicine, 11(20), 3854–3862. https://doi.org/10.1002/cam4.4758
6.
BurghleA.LundbyC.RygJ.SøndergaardJ.PottegårdA.NielsenD.GraabækT. (2020). Attitudes towards deprescribing among older adults with limited life expectancy and their relatives: A systematic review. Drugs Aging, 37(7), 503–520. https://doi.org/10.1007/s40266-020-00774-x
ChoH.KlabundeC. N.YabroffK. R.WangZ.MeekinsA.Lansdorp-VogelaarI.MariottoA. B. (2013). Comorbidity-adjusted life expectancy: A new tool to inform recommendations for optimal screening strategies. Annals of Internal Medicine, 159(10), 667–676.
9.
ChungC. (2018). Older adults may Not consider life expectancy an important factor in cancer screening. CA: A Cancer Journal for Clinicians, 68(1), 3–4.
10.
ClarkeM. G.EwingsP.HannaT.DunnL.GirlingT.WiddisonA. L. (2009). How accurate are doctors, nurses and medical students at predicting life expectancy?European Journal of Internal Medicine, 20(6), 640–644. https://doi.org/10.1016/j.ejim.2009.06.009
11.
CollaC. H.MordenN. E.SequistT. D.SchperoW. L.RosenthalM. B. (2015). Choosing wisely: Prevalence and correlates of low-value health care services in the United States. Journal of General Internal Medicine, 30(2), 221–228. https://doi.org/10.1007/s11606-014-3070-z
12.
DossettL. A.MottN. M.BredbeckB. C.WangT.JobinC. T.HughesT. M.. . .Zikmund-FisherB. J. (2022). Using tailored messages to target overuse of low-value breast cancer care in older women. Journal of Surgical Research, 270, 503–512.
13.
EloS.KyngäsH. (2008). The qualitative content analysis process. Journal of Advanced Nursing, 62(1), 107–115.
14.
GrossC. P.FriedT. R.TinettiM. E.RossJ. S.GenaoI.HossainS.. . .LewisC. L. (2015). Decision-making and cancer screening: A qualitative study of older adults with multiple chronic conditions. Journal of Geriatric Oncology, 6(2), 93–100.
15.
HaggstromD. A.KlabundeC. N.SmithJ. L.YuanG. (2013). Variation in primary care physicians’ colorectal cancer screening recommendations by patient age and comorbidity. Journal of general internal medicine, 28, 18–24.
16.
HallenS. A.HootsmansN. A.BlaisdellL.GutheilC. M.HanP. K. (2015). Physicians’ perceptions of the value of prognostic models: The benefits and risks of prognostic confidence. Health Expectations, 18(6), 2266–2277. https://doi.org/10.1111/hex.12196
17.
HoffmanR. M.LewisC. L.PignoneM. P.CouperM. P.BarryM. J.ElmoreJ. G.. . .Zikmund-FisherB. J. (2010). Decision-making processes for breast, colorectal, and prostate cancer screening: The DECISIONS survey. Medical Decision Making: An International Journal of the Society for Medical Decision Making, 30(Suppl.5), 53S–64S. https://doi.org/10.1177/0272989X10378701
18.
HoustenA. J.PappadisM. R.KrishnanS.WellerS. C.GiordanoS. H.BeversT. B.. . .HooverD. S. (2018). Resistance to discontinuing breast cancer screening in older women: A qualitative study. Psycho-Oncology, 27(6), 1635–1641.
19.
JanssenE. M.PollackC. E.BoydC.BridgesJ. F.XueQ.-L.WolffA. C.SchoenbornN. L. (2019). How do older adults consider age, life expectancy, quality of life, and physician recommendations when making cancer screening decisions? Results from a national survey using a discrete choice experiment. Medical Decision Making, 39(6), 621–631.
20.
KistlerC. E.LewisC. L.AmickH. R.BynumD. L.WalterL. C.WatsonL. C. (2006). Older adults’ beliefs about physician-estimated life expectancy: A cross-sectional survey. BMC Family Practice, 7(1), Article 9.
21.
KobayashiL. C.von WagnerC.WardleJ. (2017). Perceived life expectancy is associated with colorectal cancer screening in England. Annals of Behavioral Medicine, 51(3), 327–336. https://doi.org/10.1007/s12160-016-9855-z
22.
KotwalA. A.WalterL. C. (2020). Cancer screening in older adults: Individualized decision-making and communication strategies. Medical Clinics of North America, 104(6), 989–1006. https://doi.org/10.1016/j.mcna.2020.08.002
23.
KotwalA. A.WalterL. C.LeeS. J.DaleW. (2019). Are we choosing wisely? Older adults’ cancer screening intentions and recalled discussions with physicians about stopping. Journal of General Internal Medicine, 34(8), 1538–1545.
24.
LantzP. M.UbelP. A. (2005). The use of life expectancy in cancer screening guidelines: Moving with caution from model-based evidence to evidence-based guidelines. Journal of General Internal Medicine, 20(6), 552–553.
25.
LeeK. T.HarrisR. P.SchoenbornN. L. (2018). Individualized approach to cancer screening in older adults. Clinics in Geriatric Medicine, 34(1), 11–23. https://doi.org/10.1016/j.cger.2017.09.002
26.
LeeS. J.BoscardinW. J.Stijacic-CenzerI.Conell-PriceJ.O’BrienS.WalterL. C. (2013). Time lag to benefit after screening for breast and colorectal cancer: Meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ, 346, Article e8441.
27.
LeeS. J.LeipzigR. M.WalterL. C. (2013). Incorporating lag time to benefit into prevention decisions for older adults. Journal of the American Medical Association, 310(24), 2609–2610.
28.
LewisC. L.CouperM. P.LevinC. A.PignoneM. P.Zikmund-FisherB. J. (2010). Plans to stop cancer screening tests among adults who recently considered screening. Journal of General Internal Medicine, 25(8), 859–864. https://doi.org/10.1007/s11606-010-1346-5
29.
LewisC. L.EssermanD.DeLeonC.PignoneM. P.PathmanD. E.GolinC. (2013). Physician decision making for colorectal cancer screening in the elderly. Journal of General Internal Medicine, 28(9), 1202–1207.
30.
LewisC. L.GriffithJ.PignoneM. P.GolinC. (2009). Physicians’ decisions about continuing or stopping colon cancer screening in the elderly: A qualitative study. Journal of General Internal Medicine, 24(7), 816–821.
31.
LewisC. L.KistlerC. E.AmickH. R.WatsonL. C.BynumD. L.WalterL. C.PignoneM. P. (2006). Older adults’ attitudes about continuing cancer screening later in life: A pilot study interviewing residents of two continuing care communities. BMC Geriatrics, 6(1), Article 10.
32.
LewisC. L.MooreC. G.GolinC. E.GriffithJ.Tytell-BrennerA.PignoneM. P. (2008). Resident physicians’ life expectancy estimates and colon cancer screening recommendations in elderly patients. Medical Decision Making, 28(2), 254–261. https://doi.org/10.1177/0272989x07311756
33.
MoréJ. M.Lang-BrownS.RomoR. D.LeeS. J.SudoreR.SmithA. K. (2018). “Planting the seed”: Perceived benefits of and strategies for discussing long-term prognosis with older adults. Journal of the American Geriatrics Society, 66(12), 2367–2371. https://doi.org/10.1111/jgs.15524
34.
NortonW. E.ChambersD. A. (2020). Unpacking the complexities of de-implementing inappropriate health interventions. Implementation Science, 15(1), 1–7.
35.
O’KeeffeM.NickelB.DakinT.MaherC. G.AlbarqouniL.McCafferyK.MoynihanR. (2021). Journalists’ views on media coverage of medical tests and overdiagnosis: A qualitative study. BMJ Open, 11(6), Article e043991. https://doi.org/10.1136/bmjopen-2020-043991
36.
PaulusJ. K.KentD. M. (2017). Race and ethnicity: A part of the equation for personalized clinical decision making?Circulation: Cardiovascular Quality and Outcomes, 10(7), Article e003823.
37.
PaulusJ. K.KentD. M. (2020). Predictably unequal: Understanding and addressing concerns that algorithmic clinical prediction may Increase health disparities. npj Digital Medicine, 3, Article 99. https://doi.org/10.1038/s41746-020-0304-9
38.
PollackC. E.PlatzE. A.BhavsarN. A.NoronhaG.GreenG. E.ChenS.CarterH. B. (2012). Primary care providers’ perspectives on discontinuing prostate cancer screening. Cancer, 118(22), 5518–5524. https://doi.org/10.1002/cncr.27577
39.
QaseemA.BarryM. J.DenbergT. D.OwensD. K.ShekelleP. (2013). Screening for prostate cancer: A guidance statement from the clinical guidelines committee of the American college of physicians. Annals of Internal Medicine, 158(10), 761–769.
40.
RochmanS. (2014). Cancer screening in older adults: Risks and benefits. JNCI: Journal of the National Cancer Institute, 106(12), Article dju414.
41.
RoyS.MossJ. L.Rodriguez-ColonS. M.ShenC.CooperJ. D.LennonR. P.. . .RuffinI. V. M. T. (2020). Examining older adults’ attitudes and perceptions of cancer screening and overscreening: A qualitative study. Journal of Primary Care & Community Health, 11.
42.
SalzmanB.BeldowskiK.de La PazA. (2016). Cancer screening in older patients. American Family Physician, 93(8), 659–667.
43.
SchoenbornN. L.BowmanT. L.CayeaD.BoydC.FeeserS.PollackC. E. (2016). Discussion strategies that primary care clinicians use when stopping cancer screening in older adults. Journal of the American Geriatrics Society, 64(11), e221–e223.
SchoenbornN. L.BoydC. M.LeeS. J.CayeaD.PollackC. E. (2019). Communicating about stopping cancer screening: Comparing clinicians’ and older adults’ perspectives. Gerontologist, 59(Suppl.1), S67–S76. https://doi.org/10.1093/geront/gny172
46.
SchoenbornN. L.BoydC. M.PollackC. E. (2022). Physician attitudes about using life expectancy to inform cancer screening cessation in older adults—Results from a national survey. JAMA Internal Medicine, 182, 1229–1231. https://doi.org/10.1001/jamainternmed.2022.4316
47.
SchoenbornN. L.CrossnohereN. L.JanssenE. M.PollackC. E.BoydC. M.WolffA. C.. . .BridgesJ. F. (2019). Examining generalizability of older adults’ preferences for discussing cessation of screening colonoscopies in older adults with low health literacy. Journal of General Internal Medicine, 34(11), 2512–2519.
48.
SchoenbornN. L.JanssenE. M.BoydC.BridgesJ. F.WolffA. C.XueQ.-L.PollackC. E. (2018). Older adults’ preferences for discussing long-term life expectancy: Results from a national survey. The Annals of Family Medicine, 16(6), 530–537.
SchoenbornN. L.LeeK.PollackC. E.ArmacostK.DyS. M.XueQ.-L.. . .BoydC. (2017). Older adults’ preferences for when and how to discuss life expectancy in primary care. The Journal of the American Board of Family Medicine, 30(6), 813–815. https://www.jabfm.org/content/jabfp/30/6/813.full.pdf
51.
SchoenbornN. L.MassareJ.ParkR.BoydC. M.ChoiY.PollackC. E. (2020). Assessment of clinician decision-making on cancer screening cessation in older adults with limited life expectancy. JAMA Network Open, 3(6), e206772–e206772.
52.
SchoenbornN. L.MassareJ.ParkR.PollackC. E.ChoiY.BoydC. M. (2020). Clinician perspectives on overscreening for cancer in older adults with limited life expectancy. Journal of the American Geriatrics Society, 68(7), 1462–1468.
53.
SchoenbornN. L.XueQ.-L.PollackC. E.JanssenE. M.BridgesJ. F.WolffA. C.BoydC. M. (2019). Demographic, health, and attitudinal factors predictive of cancer screening decisions in older adults. Preventive Medicine Reports, 13, 244–248.
54.
SchonbergM. A. (2018). Overutilization of breast cancer screening in the U.S.: Awareness of a growing problem. Journal of General Internal Medicine, 33(3), 238–240. https://doi.org/10.1007/s11606-017-4258-9
55.
SchonbergM. A.JacobsonA. R.KaramourtopoulosM.AlibertiG. M.PinheiroA.SmithA. K.. . .HamelM. B. (2020). Scripts and strategies for discussing stopping cancer screening with adults >75 years: A qualitative study. Journal of General Internal Medicine, 35, 2076–2083.
56.
SchonbergM. A.KaramourtopoulosM.JacobsonA. R.AlibertiG. M.PinheiroA.SmithA. K.. . .HamelM. B. (2020). A strategy to prepare primary care clinicians for discussing stopping cancer screening with adults older than 75 years. Innovation in Aging, 4(4), Article igaa027.
57.
SchwartzL.WoloshinS.FowlerF. J.JrWelchH. G. (2004). Enthusiasm for cancer screening in the United States. Journal of the American Medical Association, 291(1), 71–78.
58.
ShubellaJ.KauffmanG.KhaliqW. (2022). Hospitalized women’s perspective on willingness-to-screen for cancers in relation to life expectancy. Cureus, 14(6), Article e25732. https://doi.org/10.7759/cureus.25732
59.
SifriR.SalzmanB.CunninghamA.SilverioA.ZaleM.TalericoC. (2019). Primary care providers’ attitudes and practices regarding cancer screening in older adults. Population Health Management, 22(4), 315–320.
60.
SmithJ.DoddR. H.GaineyK. M.NaganathanV.CvejicE.JansenJ.McCafferyK. J. (2021). Patient-reported factors associated with older adults’ cancer screening decision-making: A systematic review. JAMA Network Open, 4(11), e2133406–e2133406. https://doi.org/10.1001/jamanetworkopen.2021.33406
61.
SmithJ.DoddR. H.HerschJ.CvejicE.McCafferyK.JansenJ. (2020). Effect of different communication strategies about stopping cancer screening on screening intention and cancer anxiety: A randomised online trial of older adults in Australia. BMJ Open, 10(6), Article e034061.
62.
SmithR. A.AndrewsK. S.BrooksD.FedewaS. A.Manassaram-BaptisteD.SaslowD.WenderR. C. (2019). Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 69(3), 184–210.
63.
TakslerG. B.KeshnerM.FagerlinA.HajizadehN.BraithwaiteR. S. (2013). Personalized estimates of benefit from preventive care guidelines: A proof of concept. Annals of Internal Medicine, 159(3), 161–168.
64.
TazkarjiB.LamR.LeeS.MeiyappanS. (2016). Approach to preventive care in the elderly. Canadian Family Physician, 62(9), 717–721.
65.
ThomasJ. M.FriedT. R. (2018). Defining the scope of prognosis: Primary care clinicians’ perspectives on predicting the future health of older adults. Journal of Pain and Symptom Management, 55(5), 1269–1275.e1261.
66.
TorkeA. M.SchwartzP. H.HoltzL. R.MontzK.SachsG. A. (2013). Older adults and forgoing cancer screening: “I think it would be strange.” JAMA Internal Medicine, 173(7), 526–531. https://doi.org/10.1001/jamainternmed.2013.2903
67.
VasanR. S.van den HeuvelE. (2022). Differences in estimates for 10-year risk of cardiovascular disease in Black versus White individuals with identical risk factor profiles using pooled cohort equations: An in silico cohort study. Lancet Digit Health, 4(1), e55–e63. https://doi.org/10.1016/s2589-7500(21)00236-3
68.
von WagnerC.MacedoA.CampbellC.SimonA. E.WardleJ.HammersleyV.WallerJ. (2013). Continuing cancer screening later in life: Attitudes and intentions among older adults in England. Age Ageing, 42(6), 770–775. https://doi.org/10.1093/ageing/aft132
69.
VordenbergS. E.Zikmund-FisherB. J. (2020). Characteristics of older adults predict concern about stopping medications. Journal of the American Pharmacists Association, 60, 773–780. doi:10.1016/j.japh.2020.01.019
70.
WalterL. C.CovinskyK. E. (2001). Cancer screening in elderly patients: A framework for individualized decision making. Journal of the American Medical Association, 285(21), 2750–2756. https://jamanetwork.com/journals/jama/article-abstract/193893
71.
WolfsonD.SantaJ.SlassL. (2014). Engaging physicians and consumers in conversations about treatment overuse and waste: A short history of the choosing wisely campaign. Academic Medicine, 89(7), 990–995. https://doi.org/10.1097/acm.0000000000000270
72.
WuH.Kouladjian O’DonnellL.FujitaK.MasnoonN.HilmerS. N. (2021). Deprescribing in the older patient: A narrative review of challenges and solutions. International Journal of General Medicine, 14, 3793–3807. https://doi.org/10.2147/ijgm.S253177
73.
YasmeenS.RomanoP. S.TancrediD. J.SaitoN. H.RainwaterJ.KravitzR. L. (2012). Screening mammography beliefs and recommendations: a web-based survey of primary care physicians. BMC Health Services Research, 12(1), 1–10.
74.
Zikmund-FisherB. J.KullgrenJ. T.FagerlinA.KlamerusM. L.BernsteinS. J.KerrE. A. (2017). Perceived barriers to implementing individual choosing Wisely(®) recommendations in two national surveys of primary care providers. Journal of General Internal Medicine, 32(2), 210–217. https://doi.org/10.1007/s11606-016-3853-5
